Skip to main content

12-09-2017 | Cervical cancer | Podcast | Audio

Bevacizumab in cervical cancer

The phase III GOG 240 trial evaluated bevacizumab in women with advanced cervical cancer - Advisory Board member and lead investigator Krishnansu Tewari outlines the results of the final analysis in this podcast.